TY - JOUR
T1 - SARS-CoV-2 epidemic in Brazil
T2 - how the displacement of variants has driven distinct epidemic waves
AU - Alcantara, Luiz Carlos Junior
AU - Nogueira, Elisson
AU - Shuab, Gabriel
AU - Tosta, Stephane
AU - Fristch, Hegger
AU - Pimentel, Victor
AU - Souza-Neto, Jayme A.
AU - Coutinho, Luiz Lehmann
AU - Fukumasu, Heidge
AU - Sampaio, Sandra Coccuzzo
AU - Elias, Maria Carolina
AU - Kashima, Simone
AU - Slavov, Svetoslav Nanev
AU - Ciccozzi, Massimo
AU - Cella, Eleonora
AU - Lourenco, José
AU - Fonseca, Vagner
AU - Giovanetti, Marta
N1 - Funding Information:
This work was supported in part through National Institutes of Health USA grant U01 AI151698 for the United World Arbovirus Research Network (UWARN), the CRP- ICGEB RESEARCH GRANT 2020 Project CRP/BRA20-03, Contract CRP/20/03, the Oswaldo Cruz Foundation VPGDI-027-FIO-20-2-2-30, and the Brazilian Ministry of Health (SCON2021-00180). MG is supported by Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro -FAPERJ.
Publisher Copyright:
© 2022
PY - 2022/7/2
Y1 - 2022/7/2
N2 - Brazil ranks as third in terms of total number of reported SARS-CoV-2 cases globally. The COVID-19 epidemic in Brazil was characterised by the co-circulation of multiple variants as a consequence of multiple independent introduction events occurring through time. Here, we describe the SARS-CoV-2 variants that are currently circulating and co-circulating in the country, with the aim to highlight which variants have driven the different epidemic waves. For this purpose, we retrieved metadata information of Coronavirus sequences collected in Brazil and available at the GISAID database. SARS-CoV-2 lineages have been identified along with eleven variants, labelled as VOCs (Alpha, Gamma, Beta, Delta and Omicron) VOIs (Lambda and Mu) VUMs (B.1.1.318) and FMVs (Zeta, Eta and B.1.1.519). Here we show that, in the Brazilian context, after 24 months of sustained transmission and evolution of SARS-CoV-2, local variants (among them the B.1.1.28 and B.1.1.33) were displaced by recently introduced VOCs firstly with the Gamma, followed by Delta and more recently Omicron. The rapid spread of some of those VOCs (such as Gamma and Omicron) was also mirror by a large increase in the number of cases and deaths in the country. This in turn reinforces that, due to the emergence of variants that appear to induce a substantial evasion against neutralizing antibody response, it is important to strengthen genomic effort within the country and how vaccination still remains a critical process to protect the vulnerable population, still at risk of infection and death.
AB - Brazil ranks as third in terms of total number of reported SARS-CoV-2 cases globally. The COVID-19 epidemic in Brazil was characterised by the co-circulation of multiple variants as a consequence of multiple independent introduction events occurring through time. Here, we describe the SARS-CoV-2 variants that are currently circulating and co-circulating in the country, with the aim to highlight which variants have driven the different epidemic waves. For this purpose, we retrieved metadata information of Coronavirus sequences collected in Brazil and available at the GISAID database. SARS-CoV-2 lineages have been identified along with eleven variants, labelled as VOCs (Alpha, Gamma, Beta, Delta and Omicron) VOIs (Lambda and Mu) VUMs (B.1.1.318) and FMVs (Zeta, Eta and B.1.1.519). Here we show that, in the Brazilian context, after 24 months of sustained transmission and evolution of SARS-CoV-2, local variants (among them the B.1.1.28 and B.1.1.33) were displaced by recently introduced VOCs firstly with the Gamma, followed by Delta and more recently Omicron. The rapid spread of some of those VOCs (such as Gamma and Omicron) was also mirror by a large increase in the number of cases and deaths in the country. This in turn reinforces that, due to the emergence of variants that appear to induce a substantial evasion against neutralizing antibody response, it is important to strengthen genomic effort within the country and how vaccination still remains a critical process to protect the vulnerable population, still at risk of infection and death.
KW - Brazil
KW - SARS-CoV-2
KW - Surveillance
KW - Variants
UR - http://www.scopus.com/inward/record.url?scp=85129668552&partnerID=8YFLogxK
U2 - 10.1016/j.virusres.2022.198785
DO - 10.1016/j.virusres.2022.198785
M3 - Article
C2 - 35461905
AN - SCOPUS:85129668552
SN - 0168-1702
VL - 315
JO - Virus Research
JF - Virus Research
M1 - 198785
ER -